NCT05614544View on ClinicalTrials.gov

Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 16, 2022

Primary Completion Date

October 3, 2023

Study Completion Date

October 3, 2023

Conditions
General Anesthesia
Interventions
DRUG

HSK3486

HSK3486 for induction of general anesthesia

DRUG

Propofol

Propofol for induction of general anesthesia

DRUG

Placebo

Intralipid

Trial Locations (1)

84124

ICON (LPRA) - Salt Lake, Salt Lake City

Sponsors
All Listed Sponsors
lead

Haisco-USA Pharmaceuticals, Inc.

INDUSTRY